In a clinical trial, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices, procedures, or changes to participants' behavior, such as diet. Clinical trials may compare a new medical approach to a standard one that is already available, to a placebo that contains no active ingredients, or to no intervention. Some clinical trials compare interventions that are already available to each other. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. For example, investigators may give a drug or treatment to participants who have high blood pressure to see whether their blood pressure decreases.

All medical exams, labs and other procedures are performed according to the study specific protocol and are at no cost to the patient. Insurance is not needed nor are any procedures submitted to insurance companies.  Most trials allow for reimbursement to be made to the patient for time and travel for each clinic visit that is completed. The amount of reimbursement varies by trial and visit, our study coordinators will give you specific information about this at your first clinic visit.   

Clinical Trials //

Asthma -  NCT03347279 

A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma.

 

Ages Eligible for Study:  12 Years to 80 Years  

(Child, Adult, Senior)

Sexes Eligible for Study:  All

Accepts Healthy Volunteers:  No

Asthma -  NCT03535870

The primary objective of this study is to evaluate the clinical bioequivalence of generic fluticasone propionate 100 μg and salmeterol xinafoate 50 μg inhalation powder (test) to Advair Diskus ("Advair") 100/50 (reference) for the treatment of asthma.

 

Ages Eligible for Study:  12 Years to 65 Years   (Child, Adult, Older Adult)

Sexes Eligible for Study:  All

Accepts Healthy Volunteers:  No

Asthma -  NCT03347278

Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma.

 

Ages Eligible for Study:  18 Years to 80 Years   (Adult, Older Adult)

Sexes Eligible for Study:  All

Accepts Healthy Volunteers:  No

Chronic Pain -  NCT03530345

The aim of this trial is to investigate the efficacy and safety of intravenous neridronic acid in subjects with Complex Regional Pain Syndrome (CRPS).

Ages Eligible for Study:  18 Years and older  

(Adult, Older Adult)

Sexes Eligible for Study:  All

Accepts Healthy Volunteers:  No

IBS W/Constipation - NCT03573908

 

To evaluate the efficacy on abdominal symptoms (abdominal bloating, abdominal discomfort, and abdominal pain) and safety of linaclotide 290 μg administered orally to patients with irritable bowel syndrome with constipation (IBS-C).

Eligibility
 

Ages Eligible for Study:  18 Years and older   (Adult, Older Adult)

Sexes Eligible for Study:  All

Accepts Healthy Volunteers:  No

Obesity W/Diabetes - NCT003552757

This study will look at the change in the participant's body weight from the start to the end of the study. This is to compare the effect on body weight in people taking semaglutide (a new medicine) and people taking "dummy" medicine. In addition to taking the study medicine, the participant will have talks with study staff about healthy food choices, how to be more physically active and what else the participant can do to lose weight. Overweight and obesity is associated with an increased risk of type 2 diabetes. Therefore, weight loss has shown to have a beneficial impact on the blood sugar levels. The participant will either get semaglutide or "dummy" medicine - which treatment the participant get is decided by chance. The participant will need to take 2 injections at the same time once a week. The study medicine is injected with a thin needle in a skin fold in the stomach, thigh or upper arm. The study will last for about 1.5 years.

Ages Eligible for Study:  18 Years and older   (Adult, Older Adult)

Sexes Eligible for Study:  All

Accepts Healthy Volunteers:  No

Obesity- NCT 03611582

For more information on open clinical trials, call us at: (321) 337-0700, ext 903.

©2017-2019 by The Chappel Group Research. All rights reserved.

601 East Oak Street Suite A 

Kissimmee, Florida 34744

(321) 337-0700 ext. 903

(407) 201-3965 - Fax

  • Facebook - Grey Circle
  • Twitter - Grey Circle
  • LinkedIn - Grey Circle
  • Pinterest - Grey Circle
  • Instagram - Grey Circle